All times are listed in CET (Central European Time)

Displaying One Session

View
ESMO Colloquium Channel 1

ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics

Date
Sat, 27.03.2021
Time
10:30 - 11:50
Location
Channel 1
Chairs
  • J. Vansteenkiste (Leuven, Belgium)
  • F. Cappuzzo (Ravenna, Italy)
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics ESMO Colloquium

Live introduction

Lecture Time
10:30 - 10:35
Speakers
  • J. Vansteenkiste (Leuven, Belgium)
Session Name
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics
Room
Channel 1
Date
Sat, 27.03.2021
Time
10:30 - 11:50
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics ESMO Colloquium

Molecular diagnostics for detection of RET aberrations in non-small cell lung cancer: How, when and how often

Lecture Time
10:35 - 10:50
Speakers
  • F. Penault-Llorca (Clermont-Ferrand, France)
Session Name
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics
Room
Channel 1
Date
Sat, 27.03.2021
Time
10:30 - 11:50
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics ESMO Colloquium

Targeting the RET fusion in patients with advanced non-small cell lung cancer: Efficacy, toxicity, quality of life and cost

Lecture Time
10:50 - 11:10
Speakers
  • O. Gautschi (Luzern, Switzerland)
Session Name
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics
Room
Channel 1
Date
Sat, 27.03.2021
Time
10:30 - 11:50
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics ESMO Colloquium

Two clinical cases of patients with NSCLC harbouring RET abnormalities: Critical analysis of management according to ESMO Guidelines for NSCLC and NGS use, MCBS, ESCAT

Lecture Time
11:10 - 11:30
Speakers
  • A. Passaro (Milan, Italy)
Session Name
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics
Room
Channel 1
Date
Sat, 27.03.2021
Time
10:30 - 11:50
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics ESMO Colloquium

Live conclusions

Lecture Time
11:30 - 11:35
Speakers
  • F. Cappuzzo (Ravenna, Italy)
Session Name
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics
Room
Channel 1
Date
Sat, 27.03.2021
Time
10:30 - 11:50
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics ESMO Colloquium

Q&A and live discussion

Lecture Time
11:35 - 11:50
Session Name
ESMO Colloquium co-supported by Lilly Oncology and Thermo Fisher - Targeting RET in lung cancer: State of the art in testing and therapeutics
Room
Channel 1
Date
Sat, 27.03.2021
Time
10:30 - 11:50